SiteOne Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of hypersensitivity disorders such as chronic cough, itch, and pain.

Biotechnology

SiteOne Therapeutics

SiteOne Therapeutics' headquarters in South San Francisco, CA, United States

John V. Mulcahy

Kanad Das

Joanne Bryce

John C. Hunter

Michael C. Rowbotham

Brendan Canning

Rick Orr

Lowell E. Sears

Peter Dicpinigaitis

Frank Porreca

Stephen Wexler

Stephen G. Waxman

Stan E. Abel

Scott Braunstein

Will Price

Gary D. Novack

Bradley J. Undem

Justin Du Bois

Anthony Ford

The Scientific Advisory Team at SiteOne Therapeutics provides expert guidance on the research and development of therapeutics targeting hypersensitivity disorders. Comprising seasoned scientific advisors and researchers, the team collaborates to oversee experimental design, optimize drug candidate selection, and ensures that scientific strategies align with clinical goals and regulatory standards.

Scientific Advisory Team

The Leadership Team at SiteOne Therapeutics is responsible for setting the strategic vision and direction of the company. Comprising top executives such as the Chief Scientific Officer and President & CEO, the team oversees research and development initiatives, guides clinical trial strategies, and ensures alignment with organizational goals to advance innovative therapeutics for hypersensitivity disorders.

Leadership Team

SiteOne Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Offices

Similar companies